ARPIM supports the objectives of enhancing the availability and accessibility of medicines, while fostering a competitive innovation environment in Europe. We welcome the proposal to future-proof the EU regulatory framework, maximising the use of expedited pathways, optimising regulatory decision-making processes, and reducing unnecessary administrative burdens.
ARP
ARPIM
Industry association · Romania · EU Transparency Register 983289442547-36
2
positions filed
in the 665 files tracked
1
legislative file
of 665 tracked
2
with a full position paper
attached to a submission
Counts here are a floor, never a total: they cover the 665 consultation files tracked so far (57,800 submissions, mostly 2021–26), so an organization's real filing history is larger, not smaller.
Who they are
Among the 1519 trade and business associations on this site, they rank #1177 by legislative files engaged, a count of participation, not a measure of influence.
0.8
declared lobbying FTE
self-declared
€50K+
declared costs / yr (floor)
0
EP accreditations
as declared to the register
2021
in the register since
Declares membership of
- ARPIM is affiliate member to European Federation of Pharmaceutical Industries and Associations (EFPIA) (https://www.e…
Self-declared to the EU Transparency Register (snapshot 15 Oct 2026).
- Register category
- Trade and business associations
- Registered as
- Romanian Association of International Medicines Manufacturers (ARPIM)
- Head office
- Bucharest, Romania
Self-declared to the EU Transparency Register (snapshot 15 Oct 2026); cost bands are floors, not audited totals. Reused under Commission Decision 2011/833/EU.
Track ARPIM in PolicySpeak: request access →
Work at ARPIM? so we know who speaks for it.
Their record over time
ARPIM filed 2 positions on 8 Nov 2023, across 1 of the 665 legislative files tracked here, attaching a full position paper 2 times.
What they argued
ARPIM supports the objectives of enhancing the availability and accessibility of medicines, while fostering a competitive innovation environment in Europe. We welcome the proposal to future-proof the EU regulatory framework, maximising the use of expedited pathways, optimising regulatory decision-making processes, and reducing unnecessary administrative burdens.
Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.
Put ARPIM next to another organization. Same files, same register facts, side by side. Compare →
Is this your organization?
Everything on this page comes from ARPIM’s own submissions to the European Commission. We have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.
Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.